EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Sort by

Case C-2/24 P: Appeal brought on 4 January 2024 by Teva Pharmaceutical Industries Ltd and Cephalon Inc. against the judgment of the General Court (Third Chamber, Extended Composition) delivered on 18 October 2023 in Case T-74/21, Teva Pharmaceutical Industries and Cephalon v Commission

CELEX number:
62024CN0002
Form:
Judicial information
Author:
Court of Justice
Date of document:
04/01/2024

Summary of Commission Decision of 21 September 2023 relating to a proceeding under article 101 of the treaty on the functioning of the european union and article 53 of the eea agreement (CASE AT.40760 – HAND GRENADES) (Notified under document number c(2023) 6290 final) – On 21 September 2023, the Commission adopted a Decision relating to a proceeding under Article 101 of the Treaty on the Functioning of the European Union and Article 53 of the EEA Agreement. In accordance with the provisions of Article 30 of Council Regulation (EC) No 1/2003, the Commission herewith publishes the names of the parties and the main content of the decision, including any penalties imposed, having regard to the legitimate interest of undertakings in the protection of their business secrets.

C/2023/6290

CELEX number:
52023AT40760
Form:
Summary
Author:
European Commission, Directorate-General for Competition
Date of document:
21/09/2023; Date of adoption

Final Report of the Hearing Officer – Case AT.40760 – Hand Grenades

C/2023/6290

CELEX number:
52023AT40760(01)
Form:
Report
Author:
European Commission, Directorate-General for Competition
Date of document:
18/09/2023; Date of adoption

Opinion of the Advisory Committee on Restrictive Practices and Dominant Positions at its meeting on 18 September 2023 concerning a draft Decision in case COMP AT.40760 – Hand grenades – Meeting by Video Conference – via Skype for Business – Rapporteur: Poland

C/2023/6290

CELEX number:
52023AT40760(02)
Form:
Opinion
Author:
Advisory Committee on Restrictive Practices and Dominant Positions
Date of document:
18/09/2023; Date of adoption

Case T-74/21: Judgment of the General Court of 18 October 2023 — Teva Pharmaceutical Industries and Cephalon v Commission (Competition — Agreements, decisions and concerted practices — Modafinil market — Decision finding an infringement of Article 101 TFEU — Patent dispute settlement agreement — Restriction of competition by object — Characterisation — Restriction of competition by effect — Conditions for exemption under Article 101(3) TFEU — Fines)

CELEX number:
62021TA0074
Form:
Judicial information
Author:
General Court
Date of document:
18/10/2023

Case C-224/20: Judgment of the Court (Fifth Chamber) of 17 November 2022 (request for a preliminary ruling from the Sø- og Handelsretten — Denmark) — Merck Sharp & Dohme BV, Merck Sharp & Dohme Corp., MSD Danmark ApS v Abacus Medicine A/S, and Novartis AG v Abacus Medicine A/S, and Novartis AG v Abacus Medicine A/S, and Novartis AG v Paranova Danmark A/S, and H. Lundbeck A/S v Paranova Danmark A/S, and MSD Danmark ApS, MSD Sharp & Dohme GmbH, Merck Sharp & Dohme Corp. v 2CARE4 ApS, and Ferring Lægemidler A/S v Paranova Danmark A/S (Reference for a preliminary ruling — Articles 34 and 36 TFEU — Free movement of goods — Intellectual property — Trade marks — Regulation (EU) 2017/1001 — EU trade mark — Article 9(2) — Article 15 — Directive (EU) 2015/2436 — Approximation of the laws of the Member States relating to trade marks — Article 10(2) — Article 15 — Rights conferred by a trade mark — Exhaustion of the rights conferred by a trade mark — Parallel import of medicinal products — Repackaging of the product bearing the mark — New outer packaging — Replacement of the trade mark appearing on the original outer packaging by another product name — Reaffixing of the trade mark of the proprietor specific to the product, to the exclusion of the other distinctive marks or signs appearing on that original outer packaging — Opposition by the proprietor of the mark — Artificial partitioning of the markets between Member States — Medicinal products for human use — Directive 2001/83/EC — Article 47a — Safety features — Replacement — Equivalent features — Delegated Regulation (EU) 2016/161 — Article 3(2) — Anti-tampering device)

CELEX number:
62020CA0224
Form:
Judicial information
Author:
Court of Justice
Date of document:
17/11/2022
Number of pages:
3

Commission Regulation (EU) 2022/2456 of 8 December 2022 amending Regulation (EU) No 1218/2010 on the application of Article 101(3) of the Treaty on the Functioning of the European Union to certain categories of specialisation agreements (Text with EEA relevance)

C/2022/8874

Legal status of the documentIn force

CELEX number:
32022R2456
Form:
Regulation
Author:
European Commission, Directorate-General for Competition
Date of document:
08/12/2022; Date of adoption
Number of pages:
2
Sort by
2
Domain: All, EUROVOC descriptor: market-sharing agreement, Search language: English